171 related articles for article (PubMed ID: 21671473)
21. Tibolone and endometrial cancer: a cohort and nested case-control study in the UK.
de Vries CS; Bromley SE; Thomas H; Farmer RD
Drug Saf; 2005; 28(3):241-9. PubMed ID: 15733028
[TBL] [Abstract][Full Text] [Related]
22. Fish consumption and risk of gastrointestinal cancers: a meta-analysis of cohort studies.
Yu XF; Zou J; Dong J
World J Gastroenterol; 2014 Nov; 20(41):15398-412. PubMed ID: 25386090
[TBL] [Abstract][Full Text] [Related]
23. Postmenopausal hormone therapy and stroke: role of time since menopause and age at initiation of hormone therapy.
Grodstein F; Manson JE; Stampfer MJ; Rexrode K
Arch Intern Med; 2008 Apr; 168(8):861-6. PubMed ID: 18443262
[TBL] [Abstract][Full Text] [Related]
24. Bisphosphonate use and gastrointestinal tract cancer risk: meta-analysis of observational studies.
Oh YH; Yoon C; Park SM
World J Gastroenterol; 2012 Oct; 18(40):5779-88. PubMed ID: 23155320
[TBL] [Abstract][Full Text] [Related]
25. Menopausal hormone therapy and risk of oesophageal adenocarcinoma in a population-based cohort study.
Xie SH; Santoni G; Lagergren J
Br J Cancer; 2022 Jan; 126(1):129-133. PubMed ID: 34671128
[TBL] [Abstract][Full Text] [Related]
26. The effect of menopausal hormone therapy on gastrointestinal cancer risk and mortality in South Korea: a population-based cohort study.
Nam JH; Jang SI; Park HS; Kim JH; Lee JK; Lim YJ; Koh MS; Lee JH; Park S; Nam CM; Park EC
BMC Gastroenterol; 2021 Nov; 21(1):440. PubMed ID: 34814853
[TBL] [Abstract][Full Text] [Related]
27. Oral contraceptive use and risk of colorectal cancer.
Fernandez E; La Vecchia C; Franceschi S; Braga C; Talamini R; Negri E; Parazzini F
Epidemiology; 1998 May; 9(3):295-300. PubMed ID: 9583422
[TBL] [Abstract][Full Text] [Related]
28. Hormone therapy and risk of lung cancer: a meta-analysis.
Oh SW; Myung SK; Park JY; Lym YL; Ju W
J Womens Health (Larchmt); 2010 Feb; 19(2):279-88. PubMed ID: 20095904
[TBL] [Abstract][Full Text] [Related]
29. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
30. Plasma sex hormone concentrations and subsequent risk of breast cancer among women using postmenopausal hormones.
Tworoger SS; Missmer SA; Barbieri RL; Willett WC; Colditz GA; Hankinson SE
J Natl Cancer Inst; 2005 Apr; 97(8):595-602. PubMed ID: 15840882
[TBL] [Abstract][Full Text] [Related]
31. [Hormone replacement therapy in menopause and risk of breast cancer].
Clavel-Chapelon F; Hill C
Presse Med; 2000 Oct; 29(31):1688-93. PubMed ID: 11094609
[TBL] [Abstract][Full Text] [Related]
32. Gastrointestinal cancer incidence in type 2 diabetes mellitus; results from a large population-based cohort study in the UK.
de Jong RGPJ; Peeters PJHL; Burden AM; de Bruin ML; Haak HR; Masclee AAM; de Vries F; Janssen-Heijnen MLG
Cancer Epidemiol; 2018 Jun; 54():104-111. PubMed ID: 29705628
[TBL] [Abstract][Full Text] [Related]
33. Menopausal hormone therapy and the risk of esophageal and gastric cancer.
Brusselaers N; Maret-Ouda J; Konings P; El-Serag HB; Lagergren J
Int J Cancer; 2017 Apr; 140(7):1693-1699. PubMed ID: 28006838
[TBL] [Abstract][Full Text] [Related]
34. Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers.
Eisen A; Lubinski J; Gronwald J; Moller P; Lynch HT; Klijn J; Kim-Sing C; Neuhausen SL; Gilbert L; Ghadirian P; Manoukian S; Rennert G; Friedman E; Isaacs C; Rosen E; Rosen B; Daly M; Sun P; Narod SA;
J Natl Cancer Inst; 2008 Oct; 100(19):1361-7. PubMed ID: 18812548
[TBL] [Abstract][Full Text] [Related]
35. The association of polymorphisms in hormone metabolism pathway genes, menopausal hormone therapy, and breast cancer risk: a nested case-control study in the California Teachers Study cohort.
Lee E; Schumacher F; Lewinger JP; Neuhausen SL; Anton-Culver H; Horn-Ross PL; Henderson KD; Ziogas A; Van Den Berg D; Bernstein L; Ursin G
Breast Cancer Res; 2011 Apr; 13(2):R37. PubMed ID: 21457551
[TBL] [Abstract][Full Text] [Related]
36. Lifetime weight history and endometrial cancer risk by type of menopausal hormone use in the NIH-AARP diet and health study.
Chang SC; Lacey JV; Brinton LA; Hartge P; Adams K; Mouw T; Carroll L; Hollenbeck A; Schatzkin A; Leitzmann MF
Cancer Epidemiol Biomarkers Prev; 2007 Apr; 16(4):723-30. PubMed ID: 17416763
[TBL] [Abstract][Full Text] [Related]
37. Concurrent use of Chinese herbal medicine among hormone users and its association with ischemic stroke risk: A population-based study.
Wen SH; Chang WC; Hong MK; Wu HC
J Ethnopharmacol; 2018 Apr; 216():274-282. PubMed ID: 29366767
[TBL] [Abstract][Full Text] [Related]
38. Use of compounded hormone therapy in the United States: report of The North American Menopause Society Survey.
Gass ML; Stuenkel CA; Utian WH; LaCroix A; Liu JH; Shifren JL;
Menopause; 2015 Dec; 22(12):1276-84. PubMed ID: 26382314
[TBL] [Abstract][Full Text] [Related]
39. Different menopausal hormone regimens and risk of breast cancer.
Brusselaers N; Tamimi RM; Konings P; Rosner B; Adami HO; Lagergren J
Ann Oncol; 2018 Aug; 29(8):1771-1776. PubMed ID: 29917061
[TBL] [Abstract][Full Text] [Related]
40. Concurrent use of statins and hormone therapy and risk of venous thromboembolism in postmenopausal women: a population-based case-control study.
Fournier JP; Duijnhoven RG; Renoux C; Dell'Aniello S; Klungel OH; Suissa S
Menopause; 2014 Sep; 21(9):1023-6. PubMed ID: 24937027
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
